Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA033399-17
Application #
6047112
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1982-07-01
Project End
2003-05-31
Budget Start
1998-08-01
Budget End
1999-05-31
Support Year
17
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Kohrt, Holbrook E; Thielens, Ariane; Marabelle, Aurelien et al. (2014) Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies. Blood 123:678-86
Myklebust, June H; Irish, Jonathan M; Brody, Joshua et al. (2013) High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells. Blood 121:1367-76
Goldstein, Matthew J; Kohrt, Holbrook E; Houot, Roch et al. (2012) Adoptive cell therapy for lymphoma with CD4 T cells depleted of CD137-expressing regulatory T cells. Cancer Res 72:1239-47
Ai, Weiyun Z; Kohrt, Holbrook E K; Timmerman, John et al. (2011) Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma. Am J Hematol 86:515-8
Kohrt, Holbrook E; Houot, Roch; Goldstein, Matthew J et al. (2011) CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies. Blood 117:2423-32
Younes, Sheren F; Beck, Andrew H; Ohgami, Robert S et al. (2011) The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow. Am J Clin Pathol 135:697-708
Temmins, Caroline; Zhao, Shuchun; Lossos, Izidore S et al. (2011) HGAL protein expression persists in disorders of germinal center dissolution: potential role of HGAL in the germinal center microenvironment. Appl Immunohistochem Mol Morphol 19:266-72
Goldstein, Matthew J; Varghese, Bindu; Brody, Joshua D et al. (2011) A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors. Blood 117:118-27
Irish, Jonathan M; Myklebust, June H; Alizadeh, Ash A et al. (2010) B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression. Proc Natl Acad Sci U S A 107:12747-54
Nicodemus, Christopher F; Wang, Lin; Lucas, Julie et al. (2010) Toll-like receptor-3 as a target to enhance bioactivity of cancer immunotherapy. Am J Obstet Gynecol 202:608.e1-8

Showing the most recent 10 out of 146 publications